Does Wegovy Work? Real Results, Side Effects & What to Expect

What Is Wegovy and How Does It Work?

Wegovy is the brand name for semaglutide 2.4 mg, a once-weekly injectable medication FDA-approved for chronic weight management in adults with obesity or overweight plus at least one weight-related condition. It belongs to a class of drugs called GLP-1 receptor agonists, which mimic a natural gut hormone that your body releases after eating.

When you inject Wegovy, semaglutide binds to GLP-1 receptors throughout your body — in your brain, pancreas, and digestive tract. In the brain, it reduces appetite signals and increases the feeling of fullness. In the gut, it slows how quickly food moves through your stomach. The combined effect is that most people feel satisfied with significantly less food and have fewer intense hunger cravings.

This is fundamentally different from older stimulant-based diet pills. Wegovy doesn't make you jittery or artificially suppress your mood — it works with your biology to recalibrate hunger signals that obesity itself can dysregulate. You can learn more about how semaglutide works on our treatment page.

What the Clinical Trials Actually Show

The landmark STEP trials (Semaglutide Treatment Effect in People with obesity) are the primary clinical evidence behind Wegovy. These were large, rigorous randomized controlled trials published in the New England Journal of Medicine.

In the STEP 1 trial, adults with obesity (without diabetes) who received Wegovy 2.4 mg lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group. To put that in real terms: someone starting at 250 pounds could expect to lose approximately 37 pounds on average.

Key findings across the STEP program:

• Nearly 70% of participants lost at least 10% of body weight
• About 50% lost at least 15% of body weight
• Roughly 32% lost 20% or more of body weight
• Most weight loss occurred in the first 60–65 weeks, then plateaued

Importantly, participants in STEP trials also followed lifestyle counseling. The medication works best alongside healthy eating and regular movement — it isn't a passive fix, but it makes those habits significantly easier to sustain.

How does Wegovy compare to Zepbound (tirzepatide)? Head-to-head trials suggest tirzepatide produces slightly greater weight loss on average, but both medications are highly effective and the right choice depends on your health profile and how your body responds.

Setting Realistic Expectations

Clinical averages don't tell the whole story. Individual results vary significantly based on genetics, diet, activity level, starting weight, and metabolic health. Some people lose 5% of body weight; others lose 25% or more. Both outcomes are within the documented range.

What you can realistically expect on a typical Wegovy timeline:

• Weeks 1–4: Starting at a low dose (0.25 mg) to minimize side effects. You may notice reduced appetite but minimal weight change yet.
• Months 2–3: Dose is titrated upward. Most people begin noticing real appetite reduction and steady weight loss of 1–2 lbs per week.
• Months 4–12: The most active weight loss phase. Sticking with lifestyle habits during this window drives the best outcomes.
• 12+ months: Weight loss typically slows or plateaus as your body reaches a new set point. Some people switch to a maintenance dose; others may transition to a different GLP-1 option.

One important note: weight often returns when Wegovy is stopped if lifestyle changes haven't been fully embedded. Chronic weight management usually means long-term use or a thoughtful transition plan with your provider.

Common Side Effects of Wegovy

Wegovy's side effects are well-documented from clinical trials and real-world use. The vast majority are gastrointestinal and are most prominent during dose escalation.

Common side effects (affecting 10–40% of users):

• Nausea — the most common, especially early on
• Vomiting
• Diarrhea or constipation
• Stomach discomfort or bloating
• Decreased appetite (intended effect that can feel uncomfortable at first)

Less common but notable:

• Headache
• Fatigue, especially early in treatment
• Injection site reactions (mild redness or irritation)
• Muscle loss — possible if protein intake and resistance exercise aren't prioritized

Most GI side effects diminish significantly after the first few weeks at each dose level and resolve for most people within the first 2–3 months. Eating smaller, lower-fat meals and avoiding very spicy or rich foods helps substantially.

Wegovy carries a boxed warning about a potential risk of thyroid C-cell tumors based on animal studies; it is contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome. A licensed provider will screen for these before prescribing.

How to Maximize Your Results on Wegovy

The people who get the best results from Wegovy typically combine the medication with intentional lifestyle changes. Here's what the evidence supports:

• Prioritize protein. Aim for 0.7–1g of protein per pound of target body weight. High protein intake helps preserve muscle during weight loss and keeps you fuller longer.
• Don't skip meals. Paradoxically, some people eat so little that their metabolism slows. Consistent, balanced meals support sustainable loss.
• Resistance train. Even 2 sessions per week of strength training helps preserve lean muscle mass as fat is lost.
• Stay hydrated. Dehydration worsens nausea and can be mistaken for hunger.
• Follow the dose titration schedule. Going up in dose too quickly dramatically increases side effects without improving outcomes.
• Work with a provider. Regular check-ins help you adjust your plan, troubleshoot side effects, and stay on track.

If you're considering starting Wegovy, Truventa's licensed providers can evaluate your eligibility and create a personalized treatment plan — all online, in all 50 states.

Who Qualifies for Wegovy?

Wegovy is FDA-approved for adults who meet one of the following criteria:

• BMI ≥ 30 (obesity)
• BMI ≥ 27 (overweight) plus at least one weight-related condition such as type 2 diabetes, hypertension, high cholesterol, or sleep apnea

It is not appropriate for people who are pregnant, have a personal or family history of certain thyroid cancers, or have had severe pancreatitis. A thorough intake with a licensed provider helps determine if Wegovy is the right fit — or whether an alternative like tirzepatide might be more suitable.